Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

NCT01879319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia
Mixed Dyslipidemia

Interventions

BIOLOGICAL: Evolocumab AMD
BIOLOGICAL: Evolocumab AI/pen

Sponsor

Amgen